510(k) K820069
K820069 is an FDA 510(k) premarket notification submitted by Burroughs Wellcome Co. for the device "WELLCOGEN GROUP B". The FDA issued a decision of Substantially Equivalent on February 18, 1982. The device falls under product code GTZ (Antisera, All Groups, Streptococcus Spp.), a Class I device regulated under 21 CFR 866.3740. Burroughs Wellcome Co. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 18, 1982
- Date Received
- January 12, 1982
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antisera, All Groups, Streptococcus Spp.
- Device Class
- Class I
- Regulation Number
- 866.3740
- Review Panel
- MI
- Submission Type